Dawn Platform
Dawn Health A/S · Operations & Productivity
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 8 captures on record
What the publisher says
As described on Microsoft Marketplace.
The Dawn Platform is designed to support participants in clinical trials and studies, patients on therapy, and healthcare professionals by streamlining onboarding, enabling adherence and symptom tracking, and simplifying the collection of structured patient-reported data (including ePROs). Built on Dawn Health’s modular platform, the solution suite offers guided patient experiences, structured data collection, and secure communication tools that can be configured for study, therapy, or disease-area–specific needs, all supported by Dawn Health’s ISO 13845- and ISO 27001-certified QMS
The Dawn Platform Product comprises pre-built, configurable digital companions for:
Show the rest of the publisher’s description (20 more lines)
· Clinical trial and study companions, supporting real-world evidence generation and ePRO collection
· Therapy companions, providing personalized education, reminders, and treatment support
· Disease management solutions, enhancing ongoing care and giving HCPs and pharma visibility into disease progression and long-term outcomes
With seamless extensions via AI-driven features, the product can provide automated guidance for patients, assist with routine questions, and support personalization, while directing more complex issues to healthcare teams. The solution integrates into existing pharma and healthcare ecosystems and is designed for compliant, scalable deployment across markets.
Currently containing a hypothetical price which will be created with customizable details (SLAs, configurations) to be defined in partnership with clients.
Customer need or pain addressed
Life sciences companies face increasing pressure to improve trial and therapy outcomes, ensure patient engagement, and collect high-quality data while meeting regulatory and data privacy requirements across multiple markets. Patients often struggle with complex study participation, therapy regimens, and long-term disease management, including a lack of clear guidance and inconsistent digital experiences. Healthcare providers need timely, structured information to support decision-making, but cannot absorb additional manual data collection or fragmented tools.
The Dawn Platform Product addresses these challenges by:
· Simplifying onboarding and engagement through intuitive, patient-centric apps for studies, therapies, and disease management
· Capturing structured patient-reported data (including ePROs) and disease-specific measures to support real-world evidence generation and therapy insights
· Offering AI-enabled support for reminders, symptom tracking, and routine guidance, while ensuring escalation paths to healthcare teams
· Enabling faster, compliant, and scalable deployment of digital health solutions using a modular, pre-built product suite tested with leading pharma partners
Key Features
· Patient onboarding - Guided signup and digital onboarding flows for clinical trials, therapies, and disease management programs
· eConsent (where applicable) - Secure digital consent capture, version control, and audit-ready documentation to support clinical and digital use cases
· Adherence and reminder support - Smart reminders for treatments, study tasks, and appointments, configurable by indication and program type
· ePRO and symptom collection - Flexible, configurable questionnaires and symptom trackers with multiple data types to support trials, therapy monitoring, and disease management
· HCP and investigator dashboards - Real-time overview of engagement, ePRO submissions, and disease metrics to inform clinical decision-making and study oversight
· Appointment and care journey management - Tools to book and manage clinical visits, track key milestones along the patient journey, and support coordinated care
· Modular and compliant by design – Built on Dawn Health’s ISO 13485‑certified QMS, the platform offers configurable components that support SaMD extensions, GxP‑compliant activities, and PRO research, and is ready for global deployment across regions
Preview
2 images
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment
Plans and pricing as listed
2 listedSources
Publisher resources
1 linkLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.